Kato Kaori, Noguchi Shingo, Naito Keisuke, Ikushima Issei, Hanaka Tetsuya, Yamasaki Kei, Kawanami Toshinori, Yatera Kazuhiro
Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan.
Intern Med. 2019 Jun 1;58(11):1605-1611. doi: 10.2169/internalmedicine.2177-18. Epub 2019 Feb 1.
We report a case of Nocardia exalbida (N.exalbida)-induced pneumonia in a 70-year old Japanese man with lung cancer and radiation pneumonitis. He initially received doripenem (1.5 g/day) for pneumonia treatment, and N.exalbida was identified by a clone library analysis of bronchoalveolar lavage fluid obtained from the pneumonia lesion. The doripenem dosage was therefore increased to 3.0 g/day with adjunctive trimethoprim/sulfamethoxazole, and his pneumonia improved. N. exalbida is susceptible to antibiotics; thus, in nocardiosis, N. exalbida infection might be associated with a good response to treatment, although its clinical findings are non-specific and similar to those of other Nocardia infections.
我们报告了一例由白色诺卡菌(N. exalbida)引起的肺炎病例,患者为一名70岁的日本男性,患有肺癌和放射性肺炎。他最初接受多利培南(1.5克/天)治疗肺炎,通过对从肺炎病灶获取的支气管肺泡灌洗液进行克隆文库分析鉴定出白色诺卡菌。因此,多利培南剂量增加至3.0克/天,并辅助使用甲氧苄啶/磺胺甲恶唑,他的肺炎病情有所改善。白色诺卡菌对抗生素敏感;因此,在诺卡菌病中,白色诺卡菌感染可能对治疗反应良好,尽管其临床表现不具特异性,与其他诺卡菌感染相似。